InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
WDT | Ann: Amended: Wellington Drive Technologies 2018 Annual Report | 28/03/19 | 0 | 14 | |||
|
|||||||
WDT | Ann: Wellington Drive Technologies 2018 Annual Report | 27/03/19 | 0 | 20 | |||
|
|||||||
WDT | Ann: Wellington Drive - Notification of Allotment | 27/03/19 | 0 | 20 | |||
|
|||||||
WDT | Ann: Wellington Drive announces governance changes | 27/03/19 | 0 | 20 | |||
|
|||||||
WDT | Ann: Wellington motor business update – 2019 guidance unchanged | 27/03/19 | 0 | 22 | |||
|
|||||||
WDT | Ann: Wellington 2018 results conference call slides | 12/03/19 | 0 | 159 | |||
|
|||||||
WDT | Ann: WDT achieves earnings guidance, with 36% revenue growth | 01/03/19 | 1 | 238 | |||
|
|||||||
WDT | Ann: Wellington Drive release of 2018 result | 27/02/19 | 0 | 100 | |||
|
See All Discussions